share_log

Altimmune | 4: Statement of changes in beneficial ownership of securities-Officer Roberts M Scot

SEC announcement ·  Aug 2 05:46
Summary by Futu AI
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
On July 31, 2024, Altimmune, Inc.'s Chief Scientific Officer, M Scot Roberts, completed a purchase of 650 shares of common stock at a price of $5.41 per share. Following this transaction, Roberts directly holds a total of 43,310 shares in the company. Additionally, it was disclosed that Roberts has an indirect ownership of 15 shares held by his spouse. The transaction, which is part of the direct holdings of non-derivative securities, reflects a vested interest in the company's performance by one of its key executives.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.